Cases & Deals

CARMAT completes €31.1 million share capital increase

Client(s) CARMAT SA

Jones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative to people suffering from end-stage biventricular heart failure, with its €31.1 million share capital increase, of which €27.2 million is aimed at specialized investors and €3.9 million for individuals (via the PrimaryBid platform).